Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novozymes A/S    NZYM B   DK0060336014

NOVOZYMES A/S

(NZYM B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Novozymes A/S : Interim report for the first nine months of 2020

10/21/2020 | 01:58am EST

Please read the full announcement in PDF

Attachment

  • 2020_58_Q32020_CompanyAnnouncement

© OMX, source OMX

All news about NOVOZYMES A/S
01/08NOVOZYMES A/S : completes acquisition of Microbiome Labs
AQ
01/05NOVOZYMES A/S : New enzyme makes high protein drinks taste better
PU
2020NOVOZYMES A/S : acquires Microbiome Labs and adds a strong position in the North..
PU
2020NOVOZYMES A/S : acquires Microbiome Labs
AQ
2020NOVOZYMES A/S : switches to renewable electricity in North America
PU
2020NOVOZYMES A/S : New sales reporting structure introduced. 2020 organic sales gro..
AQ
2020NOVOZYMES A/S : New bioenergy enzyme solution harnesses the untapped potential o..
PU
2020NOVOZYMES A/S : New biological solution strengthens gluten and improves dough
PU
2020NOVOZYMES A/S : Proposal of candidates to the Board of Directors
AQ
2020NOVOZYMES A/S : Change of management
AQ
More news
Financials
Sales 2020 14 103 M 2 296 M 2 296 M
Net income 2020 2 864 M 466 M 466 M
Net Debt 2020 4 403 M 717 M 717 M
P/E ratio 2020 35,8x
Yield 2020 1,49%
Capitalization 101 B 16 375 M 16 368 M
EV / Sales 2020 7,44x
EV / Sales 2021 7,23x
Nbr of Employees 6 180
Free-Float 71,9%
Chart NOVOZYMES A/S
Duration : Period :
Novozymes A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVOZYMES A/S
Short TermMid-TermLong Term
TrendsBullishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 19
Average target price 351,67 DKK
Last Close Price 365,20 DKK
Spread / Highest target 26,0%
Spread / Average Target -3,71%
Spread / Lowest Target -22,0%
EPS Revisions
Managers and Directors
NameTitle
Ester Baiget President & Chief Executive Officer
Jørgen Buhl Rasmussen Chairman
Graziela Chaluppe dos Santos Malucelli Chief Operating Officer & Executive VP
Lars Green Chief Financial Officer & Executive Vice President
Claus Crone Fuglsang Chief Scientific Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
NOVOZYMES A/S4.49%16 672
ECOLAB INC.-0.21%61 630
SIKA AG0.62%38 794
GIVAUDAN SA-4.72%36 899
EMS-CHEMIE HOLDING AG-3.87%21 576
SYMRISE AG-6.83%16 580